secwatch.observer — SEC 8-K summary
======================================

Issuer:     Neuraxis, INC (NRXS)
CIK:        0001933567
Form:       8-K
Filed at:   2024-11-25T23:59:59+00:00
Accession:  0001493152-24-047623
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Neuraxis appoints Dr. Gil Aharon to board effective Jan 1, 2025
---------------------------------------------------------------

- Dr. Gil Aharon appointed to Neuraxis board effective Jan 1, 2025, as designee of investors in recent $5M Series B financing.
- Dr. Aharon co-founded Rosalind Advisors and purchased $250,000 of Series B Convertible Preferred Stock in the transaction.
- He has not yet been assigned to any board committee; director compensation is undetermined.
- No family relationships with other directors or officers; no other material interests in related-party transactions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1933567/000149315224047623/0001493152-24-047623-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1933567/000149315224047623/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-047623

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer